Refractory Peptic Ulcer Disease
The eradication of Helicobacter pylori and the widespread use of effective antisecretory therapies, including proton pump inhibitors, have improved the management of peptic ulcer disease. However, in some patients, peptic ulcer disease is refractory to 8 to 12 weeks of standard antisecretory drug tr...
Main Author: | Hyun Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
Yong Chan Lee
2019-03-01
|
Series: | The Korean Journal of Helicobacter and Upper Gastrointestinal Research |
Subjects: | |
Online Access: | http://helicojournal.org/upload/pdf/kjhugr-2019-19-1-5.pdf |
Similar Items
-
Nonsteroidal Anti-inflammatory Drug and Aspirin-induced Peptic Ulcer Disease
by: Young Kwang Shim, et al.
Published: (2016-06-01) -
Risk Factors for the Presence of Symptoms in Peptic Ulcer Disease
by: Sang Pyo Lee, et al.
Published: (2017-11-01) -
PEPTIC ULCER FREQUENCY DIFFERENCES RELATED TO H. PYLORI OR AINES
by: Diego Michelon de CARLI, et al. -
Prevention of Non-steroidal Anti-inflammatory Drug-induced Peptic Ulcers
by: Seong Jun Chu, et al.
Published: (2020-11-01) -
The Role of Helicobacter pylori Infection in Drug-induced Peptic Ulcer
by: Jin Sung Koh, et al.
Published: (2018-06-01)